Cat no. / ID. 531001
Recombinant Albumin, AOF, is an animal-origin-free (AOF) protein designed to deliver high consistency, purity and safety for demanding molecular biology workflows.
Albumin acts as a stabilizer for enzymes and nucleic acids and can bind PCR inhibitors, helping ensure consistent amplification even from challenging samples. Its high purity, thermostability and animal-origin-free composition make it a reliable choice for demanding amplification workflows, especially where consistency and safety are priorities.
QIAGEN Recombinant Albumin, unlike animal-derived BSA, eliminates the risks of contamination, variability and regulatory hurdles, ensuring reliable results in sensitive applications.
Recombinant Albumin, AOF, is a genetically engineered protein with increased thermal stability to reduce aggregation and ensure reliable, high-yield amplification.
QIAGEN Recombinant Albumin, AOF, has improved thermal stability that minimizes protein aggregation, enhancing amplification efficiency and yield ( see Figure 1, Increased thermostability).
Recombinant Albumin exhibits low aggregate content, contributing to improved reaction performance, better stability and enhanced reproducibility in molecular biology workflows. ( See figure 2, Ultra-low aggregate content).
Recombinant Albumin is stable for at most 10 freeze–thaw cycles (from −20°C to room temperature), but the optimal storage temperature is 2–8°C. ( See Figure 3, Resistance to freeze-thaw cycles).
Recombinant Albumin, AOF, mitigates the effects of common PCR inhibitors, maintaining assay sensitivity and reproducibility ( See Figure 4, Recombinant Albumin reduces qPCR inhibition).
Albumins function as stabilizers, carriers and inhibitor-binding proteins in molecular biology reactions. By binding inhibitory molecules present in environmental samples, such as humic acid, hematin, melanin and others, they enhance stability and reproducibility in PCR, qPCR and related applications.
Recombinant Albumin, AOF, is a 66.4 kDa human serum albumin, overexpressed in yeast to deliver high purity and performance. The yeast expression system ensures lot-to-lot consistency, enabling reproducible results and seamless scalability.
| Parameter | Value |
|---|---|
| Source | Yeast (recombinant expression) |
| Concentration | 100 g/L (10%) |
| Purity | ≥95% |
| Endonuclease activity | None detected |
| Exonuclease activity | None detected |
| Protease activity | None detected |
| RNase contamination | None detected |
| Host DNA contamination | Not detectable |
| Endotoxin | <10 EU/g (tested for selected lots only, not included in CoA) |
| Bioburden | <10 cfu/mL Filter sterilized 0,2µm |
| Storage Temp | 2-8°C (do not freeze) |
| Formulation | Supplied as a solution at a concentration of 100 mg/mL in a storage buffer containing: 20mM Tris-HCl (pH 7.5), 20mM NaCl, 12mM sodium octanoate |
| Quality & Certification | Manufactured under ISO 13485 |
Why Animal-Origin Free (AOF) components matter
Traditional animal-derived proteins, such as bovine serum albumin (BSA), introduce risks and variability that can compromise sensitive molecular biology applications. Recombinant AOF albumin overcomes these limitations by delivering consistent performance, enhanced safety and regulatory confidence.
Advantages of AOF recombinant albumin:
Replacing animal-derived albumins with Recombinant Albumin, AOF, gives researchers greater reproducibility, safety and consistency, enabling robust performance in PCR, qPCR, NGS library prep and other demanding applications.
Our AOF products are developed and manufactured without any animal-derived materials at any stage of production or formulation. This ensures maximum safety, regulatory compliance and reproducibility - critical for sensitive molecular biology and diagnostic workflows.
Key criteria defining AOF status for QIAGEN Recombinant Albumin:
The Recombinant Albumin, AOF, is supplied at a concentration of 100 mg/mL in a storage buffer containing 20 mM Tris·HCl (pH 7.5), 20 mM NaCl and 12 mM sodium octanoate.
For use in PCR or qPCR reaction efficiency enhancer: depending on the sample matrix and template, albumin can be used in a final concentration ranging from 0.01 mg/mL to as high as 2 mg/mL. The recommended concentration is 1 mg/mL. Optional: For samples containing high levels of PCR inhibitors, the albumin concentration in the reaction can be increased to 2 mg/mL to enhance its anti-inhibitory effect.
Dilute albumin to the target concentration in water or an aqueous solution (e.g., 20 mM Tris pH 7.5 with 20 mM NaCl). Note: Avoid buffers with a pH close to the isoelectric point of albumin (around 5.7) to prevent the formation of precipitates.
Avoid high concentrations of DTT (>5 mM) in the final albumin solution. High concentrations of DTT are known to cause precipitation of albumin.
Thermal unfolding of QIAGEN Recombinant Albumin and competitive recombinant albumin was investigated through nano differential scanning fluorimetry (nanoDSF).
A temperature gradient ranging from 25–98°C was employed, with a controlled ramp of 1°C per minute. Unfolding events were characterized by monitoring fluorescence shifts (ratio 330 nm/350 nm).
Turbidity reflects to the protein aggregation during thermal unfolding measured by light scattering. Tagg= temperature at which an increase in light scattering is fastest. QIAGEN Recombinant Albumin lots display lower aggregation at elevated temperatures than the reference protein.
Thermostability of QIAGEN Recombinant Albumin was measured as a shift in fluorescence emission due to thermal unfolding. Tm = melting temperature at which 50% of the protein is unfolded. QIAGEN Recombinant Albumin shows increased thermostability (higher Tm compared to the competitive protein).
